The largest database of trusted experimental protocols

Bio plex pro assay

Manufactured by Bio-Rad
Sourced in United States, Japan, France

The Bio-Plex Pro Assay is a multiplex immunoassay platform developed by Bio-Rad. The assay utilizes magnetic beads coated with specific capture antibodies to detect and quantify multiple analytes in a single sample. The platform combines bead-based technology with flow cytometry detection to provide simultaneous measurement of multiple targets in a high-throughput manner.

Automatically generated - may contain errors

69 protocols using bio plex pro assay

1

Cytokine Quantification in Mouse Blood Post-Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight wild-type and IFNAR−/− mice per group were infected with each strain as described above and the blood collected 12 h p.i. by intracardiac puncture following euthanasia and stabilization with EDTA (Sigma-Aldrich) as previously described (3 (link), 4 (link)). Plasma supernatants were collected following centrifugation at 10,000 × g for 10 min at 4°C and stored at −80°C. Plasmatic concentrations of TNF, IL-6, IL-12p70, CCL2, CCL3, and CXCL1 were measured using a custom-made cytokine Bio-Plex Pro™ assay (Bio-Rad) according to the manufacturer’s instructions. Acquisition was performed on the MAGPIX platform (Luminex®) and data analyzed using the Bio-Plex Manager 6.1 software (Bio-Rad).
+ Open protocol
+ Expand
2

Liver Protein Extraction and TNF-α Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
For total protein extraction and TNF-α measurement, a modified protocol was applied as described [21 (link)]. In brief, liver tissue samples were homogenized with a QIAGEN Tissue Lyser II (Qiagen, Venlo, The Netherlands) for 2.5 min/25 Hz in extraction buffer containing 20 mM TrisHCl, 0.15 M NaCl, 2 mM EDTA, 1 mM EGTA, and a protease inhibitor cocktail (Sigma, Buchs, Switzerland). Samples were centrifuged at 1000× g for 10 min at 4 °C. Thereafter, the supernatants were removed and centrifuged a second time at 16,000× g for 120 min at 4 °C. The total protein concentration content was quantified with a coomassie dye-binding Bradford assay (Bio-Rad, Cressier, Switzerland). The TNF-α content was measured by a Luminex-based system using a mouse specific cytokines Bio-Plex Pro™ assay as described previously [21 (link)], following the standard protocol of the manufacturer (Bio-Rad).
+ Open protocol
+ Expand
3

Cytokine and HIV Replication Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines released in the supernatants were analyzed by using a customized Bio-Plex Pro Assay (BIO RAD) according to manufacturer’s instructions. The assay was able to evaluate the following cytokines and chemokines: IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12(p70), IL-13, G-CSF, IFN-γ, MCP-1, MIP-1b, RANTES, TNF-α, GM-CSF, IL-17.
HIV replication was evaluated by measuring p24 released in supernatants by a microelisa system (Vironostika HIV-1 antigen, Biomarieux) according to manufacturer’s instructions.
+ Open protocol
+ Expand
4

Cytokine and Gene Expression Analysis of Stimulated Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DC culture supernatants were collected at the indicated time points following stimulation and cytokines were quantified using Bioplex Pro Assay according to the manufacturer's instructions (BioRad, Hercules, CA). Total RNA was isolated from cultured DCs using a Qiagen RNeasy kit (Qiagen, Valencia, CA) with DNase I digestion. RNA was reverse transcribed using a SuperScript VILO cDNA synthesis kit (Life Technologies). cDNA was then used as template in TaqMan-PCR reactions according to the manufacturer's instructions. The Taqman primer and probes sets included IL-12p35 (assay ID: Mm00434165), IL-12p40 (assay ID: Mm99999067), IRF-1 (assay ID: Mm01288580), and HPRT (assay ID: Mm01545399) (Life Technologies). Reactions were performed in triplicate and analyzed using Applied Biosystems 7900HT real-time PCR system (Life Technologies). The specificity of RT-PCR was confirmed by analysis of RNA samples that had not been reverse transcribed. Results were normalized to HPRT mRNA levels and expressed as fold change relative to RNA samples from mock-infected, unstimulated DCs using the comparative threshold cycle method.
+ Open protocol
+ Expand
5

Cytokine Profiling of T Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatant samples from T cell functional assays were retained following 20-h co-culture and frozen at −80°C until required for further use. Supernatants were subsequently analyzed for secreted human IL-1β, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17A, GM-CSF, IFN-γ, MIP-1α, MIP-1β, and TNF-α according to the Bio-Plex Pro assay manufacturer’s instructions (Bio-Rad, Hercules, CA, USA). Plates were read using the Bio-Plex MAGPIX system (Bio-Rad, Hercules, CA, USA). Data were acquired using Bio-Plex Manager MP software and processed using Bio-Plex Data Pro Plus (both Bio-Rad, Hercules, CA, USA).
+ Open protocol
+ Expand
6

Bioactive Factors in Decellularized Organ Matrices

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 8

Growth factors retained in processed lung and liver tissue matrices were determined using a Bio-Plex Pro Assay (BioRad). Briefly, processed tissue was washed with saline and then freeze-dried and cryo-milled. Cryo-milled tissue (100 mg) was extracted in 1 ml tissue extraction reagent I (invitrogen) at 4° C. overnight. The supernatant was used for Bio-Plex Pro Assays (Human Angiogenesis Panel). The data shows that the decellularizing and processing of lung and liver tissues preserve the key growth factors (FGF, VEGF, PDGF) found in porcine organ matrices (table 4).

TABLE 4
ng/g
dried tissueFGFVEGFPDGFAngiopoitin-2Follistatin
Processed18.432.040.72undetectable0.72
Liver
Processed42.78.441.890.110.58
Lung

+ Open protocol
+ Expand
7

LPS-Induced Sickness Response in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were i.p. injected with bacterial lipopolysaccharide (LPS) (0.20 mg/kg; serotype 0111:B4, Sigma-Aldrich) or sterile saline (0.9% NaCl, B. Braun Vet Care) [29 (link)]. Body temperature was measured 2, 4, 6 and 24 h post-injection to evaluate sickness. Three aged mice of each genotype were sacrificed between 6 and 24 h after LPS injection as they reached a humane endpoint. A second cohort of mice was sacrificed 3 h after LPS administration, using an overdose of pentobarbital (Dolethal®, 200 mg/kg i.p., Vetoquinol). Cardiac blood was collected in Li-heparin coated tubes and centrifuged (3850 × g, 15 min, 4 °C). Plasma cytokine levels were analyzed with a customized Bio-Plex Pro Assay (Bio‐Rad Laboratories; multiplexed: IL-1-β (171G5002M), TNF-α (171G5023M), IL-10 (171G5009M), IL-6 (171G5007M)) and Luminex 200 system (Merck laboratories).
+ Open protocol
+ Expand
8

Quantifying TNF-α in Osteoarthritic Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stored supernatants from cytokine-treated osteoarthritic chondrocytes incubated with various test substances were analyzed for the level of tumor necrosis factor-α [TNF-α] using the Bio-Plex Pro Assay and the Bio-Plex 200 analyzer (Bio-Rad Laboratories, Inc., Hercules, CA, USA). In this cytokine multiplex assay, antibodies are covalently coupled to magnetic beads with a unique fluorescence dye. Thus, the concentrations of each analyte can be determined. The value below the lower limit of detection for the analyte was recorded as the lower limit of quantification (LLOQ). For example, analyzed TNF-α had an LLOQ of 3.33 pg/mL. In addition, the volume of every sample supernatant was measured to quantify proteins.
+ Open protocol
+ Expand
9

Antigen-Specific Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure antigen-specific cytokine production, we aliquoted 100 μl of splenocyte suspension (1 × 106 cells/well) into each well of a 96-well plate and cultured them for 72 h using the same protocol as above, except BrdU was not used. The concentrations of four cytokines/chemokines, interleukin (IL)-2, IL-17, interferon (IFN)-γ, and granulocyte-macrophage colony-stimulating factor (GM-CSF), in the supernatants were measured using a Bio-plex Pro™ Assay (M60-009RDPD; Bio-Rad) according to the manufacturer’s instructions. The cytokine/chemokine levels were calculated by referring to a standard curve for each molecule derived using various concentrations of standards assayed in the same manner as the supernatant samples. The detection limit for each molecule was determined by recovering the corresponding standard, and the lowest values with > 70% recovery were set as the lower detection limits. No samples were beyond the upper detection limits, and some samples were below the lower detection limits.
+ Open protocol
+ Expand
10

Biomarker profiling in postpartum women

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma and serum were collected at baseline and at the 6 months of follow‐up visit. Aliquots were stored at −80°C. N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) plasma levels were measured by routine laboratory workup as described.22 The measurement of plasma Gal3 (Human Galectin‐3 Platinum Elisa, eBiosciences, San Diego, USA), sST2 (Presage® ST2 Assay, Critical Diagnostics, San Diego, USA), serum PINP (PINP Elisa Assay, Cloud‐Clone Corp, Texas, USA), and serum PIIINP (PIIINP Elisa Assay, Cloud‐Clone Corp) was conducted according to the manufacturer's instructions. OPN was measured using Bio‐Plex Pro Assay (Human Cancer Biomarker Panel 1, Bio‐Rad, Hercules. USA).
In addition, cleavage of OPN by thrombin was measured by western blot [Anti‐Human Osteopontin (O‐17) Rabbit IgG Affinity Purify, Immuno‐Biological Laboratories Co. Japan].
We recruited 96 healthy pregnancy‐matched women without any history of cardiac disease and with a normal physical examination. Forty controls were recruited in SA, of whom 17 women were in the prepartum period and 23 were in the early postpartum period. Fifty‐six healthy women were recruited in Germany. All German controls were in the postpartum period.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!